Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanning Duoling Biotechnology is a specialized animal health company headquartered in Nanning, China, focusing on the development and manufacturing of veterinary biological products. The company is primarily recognized for its expertise in swine health, offering a range of vaccines designed to combat economically significant diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS) and Classical Swine Fever. Duoling Biotech operates advanced manufacturing facilities that adhere to national GMP standards for veterinary medicine. Through collaborations with academic institutions like Guangxi University, the company continues to innovate in the field of viral attenuation and cell culture technologies. Their mission is to provide high-quality immunological solutions to support the large-scale livestock industry in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 南宁多灵生物科技.